LÉNÁRT, Peter and Lumír KREJČÍ. DNA, the central molecule of aging. Mutation Research / Fundamental and Molecular Mechanisms of Mutagenesis. Amsterdam: Elsevier Science BV, vol. 786, "April", p. 1-7. ISSN 0027-5107. doi:10.1016/j.mrfmmm.2016.01.007. 2016.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name DNA, the central molecule of aging
Authors LÉNÁRT, Peter (703 Slovakia, belonging to the institution) and Lumír KREJČÍ (203 Czech Republic, guarantor, belonging to the institution).
Edition Mutation Research / Fundamental and Molecular Mechanisms of Mutagenesis, Amsterdam, Elsevier Science BV, 2016, 0027-5107.
Other information
Original language English
Type of outcome Article in a journal
Field of Study Genetics and molecular biology
Country of publisher Netherlands
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 1.829
RIV identification code RIV/00216224:14110/16:00088202
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1016/j.mrfmmm.2016.01.007
UT WoS 000371986800001
Keywords in English DNA; Aging; Chromatin structure; Telomeres; DNA damage; DNA repair; Mutagenesis
Tags EL OK, podil
Tags International impact, Reviewed
Changed by Changed by: Ing. Mgr. Věra Pospíšilíková, učo 9005. Changed: 19/10/2016 10:50.
Abstract
Understanding the molecular mechanism of aging could have enormous medical implications. Despite a century of research, however, there is no universally accepted theory regarding the molecular basis of aging. On the other hand, there is plentiful evidence suggesting that DNA constitutes the central molecule in this process. Here, we review the roles of chromatin structure, DNA damage, and shortening of telomeres in aging and propose a hypothesis for how their interplay leads to aging phenotypes.
Links
GAP207/12/2323, research and development projectName: Endonuleazová a translokázová aktivita v restričních-modifikáčních komplexéch typu I
Investor: Czech Science Foundation
GA13-26629S, research and development projectName: SUMO a stability genomu
Investor: Czech Science Foundation
MUNI/M/1894/2014, interní kód MUName: Development of new MUS81 nuclease inhibitors as chemical biology probe with clinical progression
Investor: Masaryk University, INTERDISCIPLINARY - Interdisciplinary research projects
PrintDisplayed: 18/4/2024 22:28